In vitro silencing of FBXW7 significantly enhanced pancreatic cancer (PC) cell proliferation, migration, and invasion and rendered resistance to gemcitabine and nab-paclitaxel due to the accumulation of MCL1 [156] (Table 1). This evidence concerns the gene FBXW7 and pancreatic neoplasm.